Carregant...
Pilot Study of a (213)Bismuth-labeled anti-CD45 MAb as a Novel Nonmyeloablative Conditioning for DLA-Haploidentical Littermate Hematopoietic Transplantation
BACKGROUND: A pilot study was conducted to determine whether conditioning using selective targeting of hematopoietic cells with an α-particle emitter, bismuth-213 ((213)Bi)-labeled anti-CD45 monoclonal antibody (MAb) is sufficient to overcome the major histocompatibility barrier in a canine model of...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2932447/ https://ncbi.nlm.nih.gov/pubmed/20351629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e3181d98c3d |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|